October 03, 2022
2 min watch
Asbell PA, et al. Longitudinal analysis of in vitro antibiotic resistance rates among bacterial pathogens collected in the ARMOR study. Presented at: American Academy of Ophthalmology meeting; Sept. 30-Oct. 3, 2022; Chicago.
Asbell reports conducting a CME presentation for Bausch + Lomb.
CHICAGO — In this Healio Video Perspective from the AAO meeting, Penny A. Asbell, MD, MBA, discusses the ARMOR study, the largest surveillance study of eye infections in the U.S.
“Methicillin resistance may be a little bit better than it was 10 years ago, but it is still here,” she said. “Multidrug resistance is still here and is something you should be thinking about when you pick that antibiotic and take care of your patient.”